CClinicalTrials.gg
CompletedNCT04420416PANDEMICUpdated Oct 3, 2023

Mental Health and Academic Performance in COVID-19

An observational study in Depression, Anxiety, sponsored by Instituto Mexicano del Seguro Social. Completed at 1 site in Mexico. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-03.

Sponsored by Instituto Mexicano del Seguro Social · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
720
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to identify the preference of the class modalities (classroom or online) in undergraduate and graduate students. Additionally, to explore if the presence of any mental state alterations such as depression or anxiety due to the COVID-19 pandemic can alter their perception of academic performance.

02

Conditions studied

  • Depression, Anxiety

Keywords

  • COVID-19
  • Depression
  • Anxiety
  • Public health
  • Academic performance
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 720 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Instituto Mexicano del Seguro Social is the lead sponsor of 124 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Undergraduate and graduate students who attend an online university course.

Inclusion criteria

  • > 18 years
  • Students of any undergraduate or graduate course who are attending their semester online

Exclusion criteria

Exclusion Criteria:

  • Students who are not attending an online course
  • Students who are not registered in a university undergraduate or graduate course.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
720 participants (actual)
Patient registry
No

Interventions

  • OtherSurvey

    The investigators will use the Spanish language validated version of the Academic Self-Concept Scale (ASCS), the Patient Health Questionnaire-9 (PHQ-9) depression screening scale, and the General Anxiety Disorder-7 (GAD-7) screening scale. Additionally, the sample will be asked about their gender, age, preference of teaching modality, and finally, if the participants have perceived a change in their performance or any change in their grades.

06

What researchers measure

Primary outcomes

  1. Academic Self-Concept Scale Score

    This scale will explore the effort and confidence of the participants. The minimum score for each facet is 10, and the maximum score is 70.

    Time frame: up to 3 months

  2. PHQ-9 Score

    This inventory will be used to identify the presence and intensity of depressive disorders. The minimum score is 0, and the maximum score is 27.

    Time frame: up to 3 months

  3. GAD-7 Score

    This questionnaire will be used to evaluate the presence and intensity of anxiety disorders. The minimum score is 0, and the maximum score is 21.

    Time frame: up to 3 months

  4. Preference of teaching method

    Students' preference of classroom or online classes.

    Time frame: up to 3 months

  5. Self perceived academic performance

    Students' perception of changes in their academic performance: got better, worse, or stayed the same.

    Time frame: up to 3 months

  6. Academic grades changes

    Students' perception of changes in their grades: got better, worse, or stayed the same.

    Time frame: up to 3 months

07

Study locations

1 site
  • Instituto Mexicano del Seguro Social
    Guadalajara, Jalisco 44329, Mexico
08

References and documents

Individual participant data

Plan to share: No — There is no plan of making individual participant data available.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04420416
Lead sponsor
Instituto Mexicano del Seguro Social
Responsible party
GONZALEZ-OJEDA ALEJANDRO (Investigador Titular D, Instituto Mexicano del Seguro Social) — Principal investigator
First posted
Jun 9, 2020
Start date
Apr 1, 2020
Primary completion
Jul 30, 2020
Completion
Jul 30, 2020
Last update
Oct 3, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion